Study Design and Rationale for IFCT- 2203 TAXIO: A Study That Aims to Evaluate the Effectiveness of a First-Line Chemotherapy Regimen Without Etoposide, Combined with Durvalumab, for Patients with Extensive Disease Small Cell Lung Cancer.
Respiratory Medicine and Research(2024)
关键词
Small cell lung cancer,Chemotherapy,Taxane,Immunotherapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要